All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AIMMUNE THERAPEUTICS, INC.: Last Reported 5/31/2020

Business Address

8000 MARINA BOULEVARD
SUITE 300
BRISBANE, CA US 94005-1884

Mailing Address

8000 MARINA BOULEVARD
SUITE 300
BRISBANE, CA US 94005-1884
Phone Number: (650) 614-5220 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 7/31/2015 6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014 3/31/2014 12/31/2013 12/31/2012
Cash and Cash Equivalents $298,418,000.00 $79,880,000.00 $76,844,000.00 $72,564,000.00 $81,058,000.00 $107,511,000.00 $78,420,000.00 $142,157,000.00 $209,324,000.00 $73,487,000.00 $73,821,000.00 $84,451,000.00 $78,714,000.00 $124,010,000.00 $76,911,000.00 $74,430,000.00 $65,045,000.00 $76,677,000.00 $112,661,000.00 -- $58,502,000.00 $65,313,000.00 $2,269,000.00 $5,322,000.00 $7,588,000.00 -- $11,951,000.00 $218,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory $4,076,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,621,000.00 $5,564,000.00 $6,766,000.00 $6,859,000.00 $8,220,000.00 $8,687,000.00 $6,543,000.00 $6,826,000.00 $8,413,000.00 $6,681,000.00 $6,063,000.00 $5,287,000.00 $2,625,000.00 $2,749,000.00 $2,338,000.00 $3,782,000.00 $4,952,000.00 $5,622,000.00 -- -- -- -- $106,000.00 -- -- -- -- --
Total Current Assets $367,820,000.00 $149,077,000.00 $202,236,000.00 $250,531,000.00 $291,391,000.00 $312,619,000.00 $261,792,000.00 $296,826,000.00 $330,297,000.00 $189,111,000.00 $218,093,000.00 $242,612,000.00 $248,872,000.00 $251,680,000.00 $152,581,000.00 $172,750,000.00 $185,231,000.00 $197,457,000.00 $217,787,000.00 -- $60,607,000.00 -- $2,375,000.00 -- -- -- -- --
Property Plant and Equipement $27,506,000.00 $28,604,000.00 $28,713,000.00 $29,414,000.00 $26,824,000.00 $26,328,000.00 $25,045,000.00 $23,265,000.00 $21,021,000.00 $17,205,000.00 $14,940,000.00 $13,142,000.00 $11,147,000.00 $10,391,000.00 $9,034,000.00 $7,032,000.00 $3,699,000.00 $2,702,000.00 $1,829,000.00 -- $1,253,000.00 -- $87,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- $314,000.00 -- $114,000.00 -- $29,000.00 -- -- -- -- --
Total Assets $420,052,000.00 $204,369,000.00 $248,398,000.00 $298,776,000.00 $344,153,000.00 $339,555,000.00 $287,463,000.00 $326,656,000.00 $361,845,000.00 $206,934,000.00 $233,670,000.00 $256,354,000.00 $276,289,000.00 $298,789,000.00 $173,727,000.00 $185,696,000.00 $199,929,000.00 $212,361,000.00 $222,814,000.00 -- $62,074,000.00 -- $2,531,000.00 -- -- -- -- --
Accounts Payable $13,952,000.00 $13,882,000.00 $11,941,000.00 $14,086,000.00 $10,517,000.00 $8,833,000.00 $13,890,000.00 $8,211,000.00 $6,252,000.00 $5,095,000.00 $4,301,000.00 $2,310,000.00 $1,676,000.00 $1,427,000.00 $1,470,000.00 $1,261,000.00 $1,791,000.00 $1,863,000.00 $1,014,000.00 -- $309,000.00 -- $478,000.00 -- -- -- -- --
Accrued Liabilities $29,128,000.00 $31,286,000.00 $29,480,000.00 $27,083,000.00 $25,588,000.00 $29,144,000.00 $23,545,000.00 $27,844,000.00 $24,127,000.00 $21,478,000.00 $16,848,000.00 $15,622,000.00 $8,440,000.00 $9,921,000.00 $10,249,000.00 $4,433,000.00 $3,395,000.00 $3,118,000.00 $1,848,000.00 -- $2,796,000.00 -- $1,259,000.00 -- -- -- -- --
Total Current Liabilities $185,005,000.00 $100,345,000.00 $95,706,000.00 $93,802,000.00 $87,852,000.00 $40,608,000.00 $40,299,000.00 $38,818,000.00 $32,753,000.00 $29,129,000.00 $23,081,000.00 $19,563,000.00 $11,571,000.00 $12,817,000.00 $13,228,000.00 $7,167,000.00 $6,531,000.00 $6,110,000.00 $3,926,000.00 -- $4,111,000.00 -- $1,860,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $1,045,989,000.00 $828,618,000.00 $810,328,000.00 $798,058,000.00 -- $775,283,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $163,000.00 $80,000.00 $140,000.00 $236,000.00 $63,000.00 $-108,000.00 $-138,000.00 $-123,000.00 $-125,000.00 $-108,000.00 $-74,000.00 $-135,000.00 $-122,000.00 $-27,000.00 $14,000.00 $31,000.00 $6,000.00 $-88,000.00 $-2,000.00 -- -- -- -- -- -- -- -- --
Accumulated Deficit $-811,112,000.00 $-724,700,000.00 $-657,800,000.00 $-593,300,000.00 $-530,449,000.00 $-476,234,000.00 $-419,236,000.00 $-367,535,000.00 $-314,982,000.00 $-265,482,000.00 $-224,316,000.00 $-192,524,000.00 $-160,027,000.00 $-134,157,000.00 $-109,081,000.00 $-86,995,000.00 $-68,856,000.00 $-53,333,000.00 $-37,325,000.00 -- $-28,334,000.00 -- $-17,517,000.00 -- -- -- -- --
Total Stockholders' Equity $235,047,000.00 $104,024,000.00 $152,692,000.00 $204,974,000.00 $256,301,000.00 $298,947,000.00 $247,164,000.00 $287,838,000.00 $329,092,000.00 $177,805,000.00 $210,589,000.00 $236,791,000.00 $264,718,000.00 $285,972,000.00 $160,499,000.00 $178,529,000.00 $193,398,000.00 $206,251,000.00 $218,888,000.00 -- $57,963,000.00 -- $671,000.00 -- -- -- $11,637,000.00 $-547,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $420,052,000.00 $204,369,000.00 $248,398,000.00 $298,776,000.00 $344,153,000.00 $339,555,000.00 $287,463,000.00 $326,656,000.00 $361,845,000.00 $206,934,000.00 $233,670,000.00 $256,354,000.00 $276,289,000.00 $298,789,000.00 $173,727,000.00 $185,696,000.00 $199,929,000.00 $212,361,000.00 $222,814,000.00 -- $62,074,000.00 -- $2,531,000.00 -- -- -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 7/31/2015 6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014 3/31/2014 12/31/2013 12/31/2012
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues $257,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $36,463,000.00 $123,987,000.00 $30,558,000.00 $63,304,000.00 $31,316,000.00 $33,029,000.00 $31,691,000.00 $35,254,000.00 $33,446,000.00 $89,325,000.00 $60,671,000.00 $22,191,000.00 $17,417,000.00 $54,642,000.00 $37,684,000.00 $11,820,000.00 $9,976,000.00 $19,816,000.00 $9,050,000.00 -- $3,131,000.00 $2,069,000.00 $8,181,000.00 $2,469,000.00 $1,801,000.00 $1,199,000.00 $3,495,000.00 --
Selling, General, and Administrative $49,138,000.00 -- -- -- $23,712,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- $66,986,000.00 $182,818,000.00 $118,216,000.00 $55,028,000.00 $215,341,000.00 $156,908,000.00 $53,813,000.00 $50,119,000.00 $133,274,000.00 $91,634,000.00 $33,004,000.00 $26,341,000.00 $81,527,000.00 $22,241,000.00 $18,286,000.00 $15,699,000.00 $35,997,000.00 $19,842,000.00 -- $10,818,000.00 $3,441,000.00 $11,132,000.00 $7,498,000.00 $2,768,000.00 $1,600,000.00 $4,758,000.00 --
Loss from Operations $-85,283,000.00 $-249,804,000.00 $-64,602,000.00 $-63,188,000.00 $-55,028,000.00 $-215,341,000.00 $-156,908,000.00 $-103,932,000.00 $-50,119,000.00 $-133,274,000.00 $-91,634,000.00 $-33,004,000.00 $-26,341,000.00 $-81,527,000.00 $-22,241,000.00 $-33,985,000.00 $-15,699,000.00 $-35,997,000.00 $-9,024,000.00 -- $-10,818,000.00 $-3,441,000.00 $-11,132,000.00 $-3,129,000.00 $-2,768,000.00 $-1,600,000.00 $-4,758,000.00 --
Loss Before Income Taxes $-86,313,000.00 $-66,155,000.00 $-181,626,000.00 $-117,067,000.00 $-54,237,000.00 $-210,691,000.00 $-153,675,000.00 $-102,002,000.00 $-49,483,000.00 $-131,269,000.00 $-31,792,000.00 $-58,367,000.00 $-25,870,000.00 $-80,824,000.00 -- -- -- $-35,816,000.00 -- -- -- -- $-11,120,000.00 -- -- -- $-4,825,000.00 --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 290,000,000 50,046,000 55,051,264 50,046,000 -- 32,925,000 -- -- -- -- --
Common Stock Shares Outstanding 65,223,000 63,779,000 63,090,000 62,660,000 62,470,000 62,142,000 58,651,000 58,461,000 58,024,000 51,091,000 50,695,000 50,396,000 50,316,000 50,204,000 42,349,000 42,304,000 42,241,000 42,238,900 42,249,431 -- 5,698,175 -- 4,252,248 -- -- -- -- --
Copyright 2020 PursePoor.com